Transcriptomics

Dataset Information

0

Bruton's Tyrosine Kinase Regulates TLR9 but not TLR7 Signaling in Human pDCs


ABSTRACT: Plasmacytoid dendritic cells (pDCs) can be activated by the endosomal TLRs, and contribute to the pathogenesis of systemic lupus erythematosus (SLE) by producing type I IFNs. Thus, blocking TLR-mediated pDC activation may represent a useful approach for the treatment of SLE. In an attempt to identify a therapeutic target for blocking TLR signaling in pDCs, we investigated the contribution of Bruton's tyrosine kinase (Btk) to the activation of pDCs by TLR7 and TLR9 stimulation by using a selective Btk inhibitor RN486. Stimulation of TLR7 and 9 with their respective agonist, namely, gardiquimod and type A CpG ODN2216, resulted in the activation of human pDCs, as demonstrated by the expression of activation markers (CD69, CD40, and CD86), elevated production of IFN-alpha and other inflammatory cytokines, as well as up-regulation of numerous genes including IFN-alpha-inducible genes and activation of interferon regulatory factor 7 (IRF7) and NF-kB. RN486 inhibited all of these events induced by TLR9, but not TLR7 stimulation, with a nanomolar potency for inhibiting type A CpG ODN2216-mediated production of cytokines (e.g., IC50=386 nM for inhibiting IFN-alpha). Our data reveal Btk as an important regulatory enzyme in the TLR9 pathway, and a potential therapeutic target for SLE and other TLR-driven diseases.

ORGANISM(S): Homo sapiens

PROVIDER: GSE41825 | GEO | 2015/10/24

SECONDARY ACCESSION(S): PRJNA178243

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2015-10-24 | E-GEOD-41825 | biostudies-arrayexpress
2008-12-01 | E-GEOD-12218 | biostudies-arrayexpress
2023-12-14 | GSE250223 | GEO
2022-08-15 | GSE211230 | GEO
2008-12-01 | GSE12218 | GEO
2015-03-04 | E-GEOD-58756 | biostudies-arrayexpress
2015-03-04 | GSE58756 | GEO
2016-07-01 | E-GEOD-70520 | biostudies-arrayexpress
2018-10-24 | GSE121704 | GEO
2016-07-01 | GSE70520 | GEO